CClinicalTrials.gg
CompletedNCT03258606Updated Feb 24, 2023

Characteristics and Outcomes of a Capacity-to-Consent Assessment Service

An observational study in Cognitive Dysfunction, sponsored by National Institutes of Health Clinical Center (CC). Completed at 1 site in United States. Open to participants aged 7 Years and older. Per ClinicalTrials.gov, last updated 2023-02-24.

Sponsored by National Institutes of Health Clinical Center (CC) · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,098
Ages
7 Years and older
Sex
All
01

Study summary

Background:

Many medical conditions such as Alzheimer s disease limit the ability of people to think clearly. For medical scientists to best study these medical conditions, they need to enroll some people who may not be able to consent to participate in research on their own. Before these individuals enroll in research it is important to assess whether they are able to consent or whether someone else will need to consent for them. The NIH Clinical Center has a team that performs these assessments. A team like this can be useful for two reasons. First, it helps to protect the rights of research participants. Second, it makes it possible to study medical conditions that could not be studied otherwise. In this study we will look back at the records of the NIH Clinical Center team to review the process and results of these assessments. We expect to learn how the capacity assessments were done. We will learn what factors make people more or less able to consent. We will learn who consented for the research participants when they could not consent on their own, for example a spouse or an adult child. These results are likely to be useful to other researchers who wish to study diseases that limit cognitive ability.

Objective:

To study the process and outcomes of capacity assessments of people who may not be able to consent to research.

Eligibility:

People of all ages, genders, races, ethnicities, and languages whose ability to consent was assessed at the NIH Clinical Center at some time during the years 1999-2016.

Design:

This study will only review existing records. There will not be any active participants.

Records will be reviewed for research only. This will take place in the Clinical Center. It will be done by staff of the Department of Bioethics and the Human Subjects Protection Unit (HSPU).

The study will collect data from the Bioethics Consult database. It will also collect data from HSPU records.

Researchers will look at demographic data. They will look at details of capacity evaluations.

Personal data will not be extracted from existing records.

Read the detailed description

Objective: To characterize the process and outcomes of capacity assessments of individuals who may be unable to consent to participate in research.

Study population: all individuals who came to the NIH Clinical Center for possible enrollment in research whose capacity to consent or assent was evaluated by the Bioethics Consultation Service (BCS), the Human Subjects Protection Unit (HSPU), or the Ability to Consent Assessment Team (ACAT), and all surrogate decision makers of individuals who were unable to consent and were allowed by protocol to give surrogate consent.

Design: Retrospective record review

Outcome measures: The primary outcome measure will be whether prospective research participants were judged to be able to consent or not. Secondary measures will include: whether the consulting team considered it ethically acceptable to enroll the participant in research; how consent was obtained for doing so; and descriptive features of the consults such as the Institute that requested the consult, protocols for which consults were requested, and diseases that prompted capacity assessments, among other descriptive characteristics.

02

Conditions studied

  • Cognitive Dysfunction

Keywords

  • Surrogate
  • Decision Making
  • Capacity to Consent
  • Cognitive Impairment
  • Enrollment
  • Natural History
03

Who can participate

Ages eligible
7 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All individuals who came to the NIH Clinical Center for possible enrollment in research whose capacity to consent or assent was evaluated by the Bioethics Consultation Service (BCS), the Human Subjects Protection Unit (HSPU), or the Ability to Consent Assessment Team (ACAT), and all surrogate decision makers of individuals who were unable to consent and were allowed by protocol to give surrogate consent.

Inclusion criteria

  • Participant ages 7 to 99
  • Participants must have undergone some type of capacity evaluation, consent or assent monitoring, or surrogate assessment, by the BCS, HSPU, or ACAT.
  • Children (or adults) who were seen by the consultation service for the purposes of either evaluating their ability to assent or for assent monitoring

Exclusion criteria

Exclusion Criteria:

-Pregnant women or prisoners will not be included

04

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,098 participants (actual)

Groups and cohorts

  • Individuals with affected capacity to consent

    Individuals with who were unable to consent and were allowed by protocol to give surrogate consent.

05

What researchers measure

Primary outcomes

  1. Whether prospective research participants were judged to be able toconsent or not.

    Whether the consulting team considered it ethically acceptable to enroll the participant in research and how consent was obtained for doing so.

    Time frame: At record review

Secondary outcomes

  1. Other measures that will be collected include demographics, results of the evaluation, kinds of research conducted and content of capacity assessments.

    Other measures that will be collected include demographics, results of the evaluation, kinds of research conducted and content of capacity assessments.

    Time frame: At record review

  2. Whether the consulting team considered it ethically acceptable toenroll the participant in research and how consent was obtained for doing so.

    Whether the consulting team considered it ethically acceptable to enroll the participant in research and how consent was obtained fordoing so.

    Time frame: At record review

06

Study locations

1 site
  • National Institutes of Health Clinical Center
    Bethesda, Maryland 20892, United States
07

Registry details

Key details

Study ID
NCT03258606
Lead sponsor
National Institutes of Health Clinical Center (CC)
Responsible party
Sponsor
First posted
Aug 23, 2017
Start date
Jun 26, 2017
Primary completion
Aug 10, 2018
Completion
Apr 9, 2021
Last update
Feb 24, 2023

Study contacts

Marion Danis, M.D.
principal investigator · National Institutes of Health Clinical Center (CC)
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion